Previous 10 | Next 10 |
Arcadia Biosciences (RKDA) Names Stan Jacot as CEO <span class="legendSpanClass">Transformational change leader and CPG veteran brings 30 years of experience building high-functioning teams, driving organizational growth</span> PR Newswire DAVIS, Calif....
Arcadia Biosciences (RKDA -1.9%) appoints Kevin Comcowich, current Chairman of the Arcadia Board of Directors, as interim CEO, effective January 1, 2022. Board of directors finalizes its search for a permanent CEO as the company further expands into the consumer packaged goods ...
Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO PR Newswire DAVIS, Calif. , Dec. 20, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness produc...
Execution of sales strategies has lagged and the previously hoped for growth of the GoodHemp product line has not materialized. Now the company trades at cash with the market giving no credence to potential growth in the remaining product lines. I, on the other hand, still see pot...
Acquisitions drive sales forward in the third quarter. Increased costs, however, lead to another negative earnings print. Body care products & GoodWheat pasta to be marketed aggressively. Will the results finally convince the market? For further details see: Arca...
Arcadia Biosciences (RKDA) Appoints Seasoned CPG Sales Executive Brian Schaffer to Senior Vice President of Sales Accomplished growth-oriented leader will drive retail launch of GoodWheat™, lead sales organization as company expands consumer health and wellness portfolio ...
Arcadia Biosciences, Inc. (RKDA) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Matt Plavan – President and Chief Executive Officer Pam Haley – Chief Financial Officer Conference Call Participants Ryan Meyers – Lake Street Capital Prese...
Arcadia Biosciences (NASDAQ:RKDA): Q3 GAAP EPS of -$0.10 beats by $0.26. Revenue of $2.38M (+643.8% Y/Y) misses by $0.12M. Shares +2.5%. Press Release For further details see: Arcadia Biosciences EPS beats by $0.26, misses on revenue
Arcadia Biosciences (RKDA) Announces Strong Third-Quarter Financial Results and Business Highlights Revenues for quarter up six-fold, year-to-date up four-fold PR Newswire DAVIS, Calif. , Nov. 15, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc . ...
Arcadia Biosciences (NASDAQ:RKDA) is scheduled to announce Q3 earnings results on Monday, November 15th, after market close. The consensus EPS Estimate is -$0.36 (+40.0% Y/Y) and the consensus Revenue Estimate is $2.5M (-99.2% Y/Y). For further details see: Arcadia Biosciences Q3 2021 E...
News, Short Squeeze, Breakout and More Instantly...
Arcadia Biosciences Inc. Company Name:
RKDA Stock Symbol:
NASDAQ Market:
Arcadia Biosciences Inc. Website:
-- CEO Stan Jacot replaced by CFO Thomas J. Schaefer -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company and been replaced by Thomas J. Schaefer,...
Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will host a call for analysts and investors after market close on May 22, 2024. The company has scheduled a conference call for 4:30 ...
-- Transaction will accelerate scaling Arcadia’s wheat IP with Above’s vertically integrated, farm-to-fork supply chain -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, and Abov...